Epizyme logo
Epizyme EPZM

Quarterly report 2022-Q2
added 08-09-2022

report update icon

Epizyme Cash Conversion Cycle 2011-2025 | EPZM

Annual Cash Conversion Cycle Epizyme

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-308 102 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
102 -308 -103

Quarterly Cash Conversion Cycle Epizyme

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -85.6 -249 - -241 -153 -3.96 -213 -200 -326 -1.22 K 54.5 41 39.7 131 189 153 153 - - 3.49 3.49 - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
189 -1.22 K -107

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
31.5 $ 4.72 0.96 % $ 783 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
-881 $ 3.32 -1.19 % $ 257 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
166 $ 25.26 -2.47 % $ 1.22 B usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
25 - -15.15 % $ 60.3 M britainBritain
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-2.85 K - -11.43 % $ 502 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
-1.55 K - -0.23 % $ 916 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
Aptorum Group Limited Aptorum Group Limited
APM
-400 $ 1.31 -1.88 % $ 7.14 M chinaChina
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
-58 $ 89.77 -0.57 % $ 96.9 B britainBritain
Anika Therapeutics Anika Therapeutics
ANIK
270 $ 9.59 1.05 % $ 141 M usaUSA
Brickell Biotech Brickell Biotech
BBI
149 - -5.38 % $ 6.06 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
49.5 - 0.49 % $ 251 B cayman-islandsCayman-islands
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
6.09 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
214 - -7.31 % $ 87 M usaUSA
Biogen Biogen
BIIB
387 $ 174.05 0.9 % $ 25.3 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
174 $ 2.33 2.08 % $ 14.6 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
946 - -6.81 % $ 3.04 B usaUSA
Baudax Bio Baudax Bio
BXRX
-14.3 - 0.59 % $ 63 K usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
141 $ 12.26 -5.4 % $ 505 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
ChromaDex Corporation ChromaDex Corporation
CDXC
23.8 - -0.88 % $ 598 M usaUSA
Axon Enterprise Axon Enterprise
AXON
86.2 $ 570.12 -1.88 % $ 43.2 B usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
391 $ 14.66 -4.25 % $ 965 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
164 - -16.75 % $ 25.8 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
65.5 - -7.23 % $ 13 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
-6.08 K $ 27.54 -1.43 % $ 1.77 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
-101 - - $ 2.18 B usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
209 $ 11.3 -1.22 % $ 731 M usaUSA
Cerus Corporation Cerus Corporation
CERS
59.2 $ 2.15 -0.23 % $ 397 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
117 - -24.86 % $ 820 K usaUSA